Literature DB >> 21906046

Investigating epilepsy in Africa: 10 years of data collection using a standardized questionnaire in 2,269 peoples with epilepsy.

Fabrice Quet1, Florentina Rafael, Edgard B Ngoungou, Mouhamadou Diagana, Michel Druet-Cabanac, Pierre M Preux.   

Abstract

PURPOSE: The need for comparable epidemiologic data on epilepsy from various locations in tropical areas has led in 1994 to the creation of a questionnaire able to standardize information. The Limoges' questionnaire was created to collect information independently of the objectives of each survey performed, and since it has been employed in various continents under tropics latitude. In Africa between 1994 and 2004, 13 epidemiologic surveys in 12 countries were performed by this means. Authors of these works were solicited to communicate their raw data on people with epilepsy (PWE).
METHODS: Information collected was aggregated in a database upon which operations of data management were processed. Undernutrition status was determined using an anthropologic method, according World Health Organization (WHO) recommendations. Factors associated with undernutrition and absence of treatment by phenobarbitone were searched for by using multivariate logistic regression. KEY
FINDINGS: Information about 2,269 PWE was collected. Mean treatment gap and undernutrition were determined, respectively, to be 30.6% [95% confidence interval (95% CI) 28.7-32.6] and 25.4% (95% CI 22.7-28.2). Factors significantly associated with undernutrition and not being treated with phenobarbitone were determined. SIGNIFICANCE: Despite the different purposes of each study, we were able to pool information in order to characterize and study particular traits of PWE in Africa. Some items of particular importance should be collected systematically and will be highlighted in a newer version of this questionnaire. Because many surveys were undertaken using this tool in tropical areas, a backward compatibility should be ensured. Wiley Periodicals, Inc.
© 2011 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21906046     DOI: 10.1111/j.1528-1167.2011.03255.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  10 in total

1.  Prevalence and factors associated with convulsive status epilepticus in Africans with epilepsy.

Authors:  Symon M Kariuki; Angelina Kakooza-Mwesige; Ryan G Wagner; Eddie Chengo; Steven White; Gathoni Kamuyu; Anthony K Ngugi; Josemir W Sander; Brian G R Neville; Charles R J Newton
Journal:  Neurology       Date:  2015-04-03       Impact factor: 9.910

2.  Growth parameters and childhood epilepsy in Hai District, Tanzania: a community-based study.

Authors:  Jane J Rogathe; Jim Todd; Ewan Hunter; Richard Walker; Antony Ngugi; Charles Newton; Kathryn Burton
Journal:  Epilepsy Res       Date:  2014-07-06       Impact factor: 3.045

3.  Addressing the treatment gap and societal impact of epilepsy in Rwanda--Results of a survey conducted in 2005 and subsequent actions.

Authors:  Fidèle Sebera; Naasson Munyandamutsa; Dirk E Teuwen; Ibrahim Pierre Ndiaye; Amadou Gallo Diop; Azita Tofighy; Paul Boon; Peter Dedeken
Journal:  Epilepsy Behav       Date:  2015-04-30       Impact factor: 2.937

4.  Clinical features, proximate causes, and consequences of active convulsive epilepsy in Africa.

Authors:  Symon M Kariuki; William Matuja; Albert Akpalu; Angelina Kakooza-Mwesige; Martin Chabi; Ryan G Wagner; Myles Connor; Eddie Chengo; Anthony K Ngugi; Rachael Odhiambo; Christian Bottomley; Steven White; Josemir W Sander; Brian G R Neville; Charles R J C Newton; Rhian Twine; F Xavier Gómez Olivé; Mark Collinson; Kathleen Kahn; Stephen Tollman; Honratio Masanja; Alexander Mathew; George Pariyo; Stefan Peterson; Donald Ndyomughenyi; Evasius Bauni; Gathoni Kamuyu; Victor Mung'ala Odera; James O Mageto; Ken Ae-Ngibise; Bright Akpalu; Francis Agbokey; Patrick Adjei; Seth Owusu-Agyei; Immo Kleinschmidt; Victor C K Doku; Peter Odermatt; Thomas Nutman; Patricia Wilkins; John Noh
Journal:  Epilepsia       Date:  2013-10-07       Impact factor: 5.864

5.  Rasmussen's Epileptogenic Encephalitis in a Tropical Country.

Authors:  Komi Assogba; Kossivi M Apetse; Kokouvi P Waklatsi; Kokou Douti; Damelan Kombate; Koffi Aa Balogou
Journal:  J Pediatr Neurosci       Date:  2018 Oct-Dec

6.  Access to antiepileptic drug therapy in children in Camagüey Province, Cuba.

Authors:  Zeina Bárzaga Arencibia; Alberto López Leyva; Yordanka Mejías Peña; Alba Rosa González Reyes; Maurilys Acosta Nápolez; Demetrio Carbonell Perdomo; Edita Fernández Manzano; Imti Choonara
Journal:  Int J Pharm Pract       Date:  2012-05-21

7.  Living with epilepsy in Lubumbashi (Democratic Republic of Congo): epidemiology, risk factors and treatment gap.

Authors:  Béatrice Koba Bora; Didier Malamba Lez; Daniel Okitundu Luwa; Marcellin Bugeme Baguma; Désiré Tshala Katumbay; Tharcisse Kayembe Kalula; Pierre Luabeya Mesu'a Kabwa
Journal:  Pan Afr Med J       Date:  2015-08-26

8.  Help seeking and suicidality among people with epilepsy in a rural low income country setting: cross-sectional survey.

Authors:  Ruth Tsigebrhan; Charlotte Hanlon; Girmay Medhin; Abebaw Fekadu
Journal:  Int J Ment Health Syst       Date:  2017-07-14

9.  Effectiveness of community health workers on identification and mobilization of persons living with epilepsy in rural Rwanda using a validated screening tool.

Authors:  Fidele Sebera; Peter Dedeken; Jeannine Kayirangwa; Josiane Umwiringirwa; Delphine Kajeneza; Nicole Alves Dos Reis; Tim Leers; Dirk E Teuwen; Paul A J M Boon
Journal:  Hum Resour Health       Date:  2022-01-21

10.  Adverse perinatal events, treatment gap, and positive family history linked to the high burden of active convulsive epilepsy in Uganda: A population-based study.

Authors:  Angelina Kakooza-Mwesige; Donald Ndyomugyenyi; George Pariyo; Stefan Swartling Peterson; Paul Michael Waiswa; Edward Galiwango; Eddie Chengo; Rachael Odhiambo; Derrick Ssewanyana; Christian Bottomley; Anthony K Ngugi; Charles R J C Newton
Journal:  Epilepsia Open       Date:  2017-03-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.